Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study

Abstract Background This study investigated the oral microbiome signatures associated with upper gastrointestinal (GI) and pancreaticobiliary cancers. Methods Saliva samples from cancer patients and age- and sex-matched healthy controls were analyzed using 16S rRNA-targeted sequencing, followed by c...

Full description

Saved in:
Bibliographic Details
Main Authors: Sujin Oh, Jaihwan Kim, Cheol Min Shin, Hyo-Jung Lee, Hye Seung Lee, Kyoung Un Park
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-024-05989-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544373391589376
author Sujin Oh
Jaihwan Kim
Cheol Min Shin
Hyo-Jung Lee
Hye Seung Lee
Kyoung Un Park
author_facet Sujin Oh
Jaihwan Kim
Cheol Min Shin
Hyo-Jung Lee
Hye Seung Lee
Kyoung Un Park
author_sort Sujin Oh
collection DOAJ
description Abstract Background This study investigated the oral microbiome signatures associated with upper gastrointestinal (GI) and pancreaticobiliary cancers. Methods Saliva samples from cancer patients and age- and sex-matched healthy controls were analyzed using 16S rRNA-targeted sequencing, followed by comprehensive bioinformatics analysis. Results Significant dissimilarities in microbial composition were observed between cancer patients and controls across esophageal cancer (EC), gastric cancer (GC), biliary tract cancer (BC), and pancreatic cancer (PC) groups (R2 = 0.067, = 0.075, = 0.068, and = 0.044; p = 0.001, = 0.001, = 0.002, and = 0.004, respectively). Additionally, the oral microbiome composition significantly differed by the four cancer sites (p = 0.001 for EC vs. GC, EC vs. BC, EC vs. PC, GC vs. BC, and GC vs. PC; p = 0.013 for BC vs. PC). We built oral metagenomic classifiers to predict cancer and selected specific microbial taxa with diagnostic properties. For EC, the classifier differentiated cancer patients and controls with good accuracy (area under the curve [AUC] = 0.791) and included three genera: Akkermansia, Escherichia-Shigella, and Subdoligranulum. For GC, the classifier exhibited high discriminative power (AUC = 0.961); it included five genera (Escherichia-Shigella, Gemella, Holdemanella, Actinomyces, and Stomatobaculum) and three species (Eubacterium sp. oral clone EI074, Ruminococcus sp. Marseille-P328, and Leptotrichia wadei F0279). However, microbial taxa with diagnostic features for BC and PC were not identified. Conclusions These findings suggested that the oral microbiome composition may serve as an indicator of tumorigenesis in upper GI and pancreaticobiliary cancers. The development of oral metagenomic classifiers for EC and GC demonstrates the potential value of microbial biomarkers in cancer screening.
format Article
id doaj-art-96e53ac4f5d041f1ba7b52c5169d1b95
institution Kabale University
issn 1479-5876
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-96e53ac4f5d041f1ba7b52c5169d1b952025-01-12T12:37:36ZengBMCJournal of Translational Medicine1479-58762025-01-0123111710.1186/s12967-024-05989-9Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control studySujin Oh0Jaihwan Kim1Cheol Min Shin2Hyo-Jung Lee3Hye Seung Lee4Kyoung Un Park5Department of Laboratory Medicine, Seoul National University College of MedicineDepartment of Internal Medicine, Seoul National University Bundang HospitalDepartment of Internal Medicine, Seoul National University Bundang HospitalDepartment of Periodontology, Section of Dentistry, Seoul National University Bundang HospitalDepartment of Pathology, Seoul National University College of MedicineDepartment of Laboratory Medicine, Seoul National University College of MedicineAbstract Background This study investigated the oral microbiome signatures associated with upper gastrointestinal (GI) and pancreaticobiliary cancers. Methods Saliva samples from cancer patients and age- and sex-matched healthy controls were analyzed using 16S rRNA-targeted sequencing, followed by comprehensive bioinformatics analysis. Results Significant dissimilarities in microbial composition were observed between cancer patients and controls across esophageal cancer (EC), gastric cancer (GC), biliary tract cancer (BC), and pancreatic cancer (PC) groups (R2 = 0.067, = 0.075, = 0.068, and = 0.044; p = 0.001, = 0.001, = 0.002, and = 0.004, respectively). Additionally, the oral microbiome composition significantly differed by the four cancer sites (p = 0.001 for EC vs. GC, EC vs. BC, EC vs. PC, GC vs. BC, and GC vs. PC; p = 0.013 for BC vs. PC). We built oral metagenomic classifiers to predict cancer and selected specific microbial taxa with diagnostic properties. For EC, the classifier differentiated cancer patients and controls with good accuracy (area under the curve [AUC] = 0.791) and included three genera: Akkermansia, Escherichia-Shigella, and Subdoligranulum. For GC, the classifier exhibited high discriminative power (AUC = 0.961); it included five genera (Escherichia-Shigella, Gemella, Holdemanella, Actinomyces, and Stomatobaculum) and three species (Eubacterium sp. oral clone EI074, Ruminococcus sp. Marseille-P328, and Leptotrichia wadei F0279). However, microbial taxa with diagnostic features for BC and PC were not identified. Conclusions These findings suggested that the oral microbiome composition may serve as an indicator of tumorigenesis in upper GI and pancreaticobiliary cancers. The development of oral metagenomic classifiers for EC and GC demonstrates the potential value of microbial biomarkers in cancer screening.https://doi.org/10.1186/s12967-024-05989-9Oral microbiomeEsophageal cancerGastric cancerBiliary tract cancerPancreatic cancerMicrobial signatures
spellingShingle Sujin Oh
Jaihwan Kim
Cheol Min Shin
Hyo-Jung Lee
Hye Seung Lee
Kyoung Un Park
Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study
Journal of Translational Medicine
Oral microbiome
Esophageal cancer
Gastric cancer
Biliary tract cancer
Pancreatic cancer
Microbial signatures
title Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study
title_full Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study
title_fullStr Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study
title_full_unstemmed Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study
title_short Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study
title_sort metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers a case control study
topic Oral microbiome
Esophageal cancer
Gastric cancer
Biliary tract cancer
Pancreatic cancer
Microbial signatures
url https://doi.org/10.1186/s12967-024-05989-9
work_keys_str_mv AT sujinoh metagenomiccharacterizationoforalmicrobiomesignaturestopredictuppergastrointestinalandpancreaticobiliarycancersacasecontrolstudy
AT jaihwankim metagenomiccharacterizationoforalmicrobiomesignaturestopredictuppergastrointestinalandpancreaticobiliarycancersacasecontrolstudy
AT cheolminshin metagenomiccharacterizationoforalmicrobiomesignaturestopredictuppergastrointestinalandpancreaticobiliarycancersacasecontrolstudy
AT hyojunglee metagenomiccharacterizationoforalmicrobiomesignaturestopredictuppergastrointestinalandpancreaticobiliarycancersacasecontrolstudy
AT hyeseunglee metagenomiccharacterizationoforalmicrobiomesignaturestopredictuppergastrointestinalandpancreaticobiliarycancersacasecontrolstudy
AT kyoungunpark metagenomiccharacterizationoforalmicrobiomesignaturestopredictuppergastrointestinalandpancreaticobiliarycancersacasecontrolstudy